Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]Status:In development | In consultationProgramme:Technology appraisal guidanceConsultation end date: 13 February 2026Expected publication date: 21 May 2026
Baxdrostat for treating uncontrolled or resistant hypertension [ID6623]Status:In development | In consultationProgramme:Technology appraisal guidanceConsultation end date: 9 February 2026Expected publication date: TBC